1Q23 Performance Overview

DELEVERAGING ACROSS OUR PRIVATE PORTFOLIO AGGREGATED LEVERAGE ACROSS OUR PRIVATE LARGE AND INVESTMENT STAGE PORTFOLIO COMPANIES AT 2.7x AS OF 31-MAR-23 ADJUSTED NET DEBT/EBITDA 31-DEC-22 CHANGE 31-Mar-23 GEORGIA CAPITAL TARGET (OVER THE CYCLE) LARGE PORTFOLIO COMPANIES Retail (pharmacy)¹ 1.6x -0.2x 1.4x Up to 1.5x Hospitals 3.4x +0.4x 3.8x Up to 2.0x Insurance (P&C and Medical) No leverage NMF No leverage No leverage INVESTMENT STAGE PORTFOLIO COMPANIES Renewable Energy² 6.4x +0.4x 6.8x Up to 6.0x Education 1.2x 0.0x 1.2x Up to 2.5x Clinics and Diagnostics 5.3x +2.1x 7.4x Up to 2.0x Georgia Capital PLC | General note: Figures for Hospitals, Retail (Pharmacy), Clinics and Diagnostics are given excluding IFRS 16 effects; Net debt/EBITDA is adjusted for capital commitments. 1. Includes the application of the minority buyout agreement. 2. Renewable energy ratio is calculated in US$. 19

View entire presentation